114 related articles for article (PubMed ID: 32414224)
1. HOXD9 aggravates the development of cervical cancer by transcriptionally activating HMCN1.
Wen D; Wang L; Tan S; Tang R; Xie W; Liu S; Tang C; He Y
Panminerva Med; 2022 Dec; 64(4):532-536. PubMed ID: 32414224
[TBL] [Abstract][Full Text] [Related]
2. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
3. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L
Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
5. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.
Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L
J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226
[TBL] [Abstract][Full Text] [Related]
6. HOXD9 promotes the growth, invasion and metastasis of gastric cancer cells by transcriptional activation of RUFY3.
Zhu H; Dai W; Li J; Xiang L; Wu X; Tang W; Chen Y; Yang Q; Liu M; Xiao Y; Zhang W; Lin J; Wang J; Liu G; Sun Y; Jiang P; Li G; Li A; Liu S; Chen Y; Wang J
J Exp Clin Cancer Res; 2019 Sep; 38(1):412. PubMed ID: 31547840
[TBL] [Abstract][Full Text] [Related]
7. MiR-320c prevents the malignant development of cervical cancer by regulating GABRP level.
Li Y; Huang Y; Zhou C; Jiang PC; Pan W
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8731-8739. PubMed ID: 32964961
[TBL] [Abstract][Full Text] [Related]
8. TGIF2 promotes cervical cancer metastasis by negatively regulating FCMR.
Jiang J; Wu RH; Zhou HL; Li ZM; Kou D; Deng Z; Dong M; Chen LH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5953-5962. PubMed ID: 32572908
[TBL] [Abstract][Full Text] [Related]
9. MiR-205 suppresses epithelial-mesenchymal transition and inhibits tumor growth of human glioma through down-regulation of HOXD9.
Dai B; Zhou G; Hu Z; Zhu G; Mao B; Su H; Jia Q
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992394
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047.
Guo J; Chen M; Ai G; Mao W; Li H; Zhou J
Biomed Pharmacother; 2019 Jul; 115():108957. PubMed ID: 31082770
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.
Wei WF; Zhou CF; Wu XG; He LN; Wu LF; Chen XJ; Yan RM; Zhong M; Yu YH; Liang L; Wang W
Cell Death Dis; 2017 Dec; 8(12):3220. PubMed ID: 29242498
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
Liu J; Li Y; Chen X; Xu X; Zhao H; Wang S; Hao J; He B; Liu S; Wang J
BMC Cancer; 2020 Oct; 20(1):1029. PubMed ID: 33109127
[TBL] [Abstract][Full Text] [Related]
13. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-186-5p inhibits the metastasis of cervical cancer by targeting FZD3.
Wang A; Wang Y; Zhan J; Chen J
J BUON; 2021; 26(3):677-683. PubMed ID: 34268920
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of CCDC3 on proliferation, migration, invasion and EMT of human cervical cancer cells.
Zhang XF; An MZ; Ma YP; Lu YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3217-3224. PubMed ID: 31081073
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
Luan X; Wang Y
Oncol Rep; 2017 Jul; 38(1):159-166. PubMed ID: 28534991
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA TP73 antisense RNA 1 facilitates the proliferation and migration of cervical cancer cells via regulating microRNA‑607/cyclin D2.
Zhang H; Xue B; Wang S; Li X; Fan T
Mol Med Rep; 2019 Oct; 20(4):3371-3378. PubMed ID: 31432138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
